Product NDC: | 52584-469 |
Proprietary Name: | Naloxone Hydrochloride |
Non Proprietary Name: | Naloxone Hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Naloxone Hydrochloride |
Administration Route(s): | PARENTERAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-469 |
Labeler Name: | General Injectables & Vaccines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072076 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101227 |
Package NDC: | 52584-469-00 |
Package Description: | 1 BOX in 1 BAG (52584-469-00) > 1 SYRINGE in 1 BOX > 2 mL in 1 SYRINGE |
NDC Code | 52584-469-00 |
Proprietary Name | Naloxone Hydrochloride |
Package Description | 1 BOX in 1 BAG (52584-469-00) > 1 SYRINGE in 1 BOX > 2 mL in 1 SYRINGE |
Product NDC | 52584-469 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naloxone Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | PARENTERAL |
Start Marketing Date | 20101227 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc. |
Substance Name | NALOXONE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |